Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence form a general practice based clinical prospective cohort study in Utrecht, the Netherlands

摘要

Conclusions-This study suggests that in the Netherlands immunisation of elderly patients with chronic lung disease against influenza is effective and cost-saving, hence these patients should be given high priority. More, preferably experimental, studies are needed to establish whether adult lung patients under 65 years in the community will also benefit from vaccina- tion. Study objective-There is little informa- tion on the potential benefit of immunis- ing all patients with chronic lung disease in the community against influenza.